Publication | Closed Access

Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart

CardiomyopathyHeart FailureCardiovascular DiseaseMedicineProminent Cardioprotective EffectsCardiovascular PharmacologyPharmacotherapyCardiovascular ToxicityPharmacologyAnthracycline-induced CardiotoxicityCardiologyDrug Resistance